Klaus Tiroch
About
Klaus Tiroch is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging.
According to data from OpenAlex, Klaus Tiroch has authored 48 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cardiology and Cardiovascular Medicine, 32 papers in Surgery and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Klaus Tiroch's work include Coronary Interventions and Diagnostics (27 papers), Cardiac Imaging and Diagnostics (13 papers) and Acute Myocardial Infarction Research (12 papers). Klaus Tiroch is often cited by papers focused on Coronary Interventions and Diagnostics (27 papers), Cardiac Imaging and Diagnostics (13 papers) and Acute Myocardial Infarction Research (12 papers). Klaus Tiroch collaborates with scholars based in Germany, United States and Italy. Klaus Tiroch's co-authors include Adnan Kastrati, Julinda Mehilli, Albert Schömig, Robert A. Byrne, Jürgen Pache, Massimiliano Fusaro, Melchior Seyfarth, S. Schulz, Steffen Maßberg and Karl‐Ludwig Laugwitz and has published in prestigious journals such as The Lancet, Circulation and The Journal of Immunology.
In The Last Decade
Klaus Tiroch
47 papers receiving 1.9k citations
Hit Papers
Peers
Klaus Tiroch
Bart J.G.L. de Smet Netherlands
Mark Midei United States
Raisuke Iijima Japan
Jacek Legutko Poland
Albert W. Chan Canada
Hongsheng Wu United States
Maurits T. Dirksen Netherlands
Ad F.M. van den Heuvel Netherlands
Elvin Kedhi Netherlands
Mehmet Çilingiroğlu United States
Citations per year, relative to Klaus Tiroch Klaus Tiroch (= 1×)
peers
Bart J.G.L. de Smet
Countries citing papers authored by Klaus Tiroch
Since
Specialization
Citations
This map shows the geographic impact of Klaus Tiroch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Tiroch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Tiroch more than expected).
Fields of papers citing papers by Klaus Tiroch
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Klaus Tiroch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Tiroch. The network helps show where Klaus Tiroch may publish in the future.
Co-authorship network of co-authors of Klaus Tiroch
This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Tiroch. A scholar is included among the top collaborators of Klaus Tiroch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Tiroch. Klaus Tiroch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Tiroch, Klaus, et al.. (2015). "First-in-man" MitraClip via pulmonary vein access through a right mini-thoracotomy in a patient with agenesis of the inferior vena cava. EuroIntervention. 10(11). 1204–1207.
2.
Cassese, Salvatore, Sebastian Kufner, Erion Xhepa, et al.. (2015). Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials. Clinical Research in Cardiology. 105(7). 575–584.
3.
Orban, Martin, Katharina Mayer, Tanja Morath, et al.. (2015). The impact of therapeutic hypothermia on on-treatment platelet reactivity and clinical outcome in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction: Results from the ISAR-SHOCK registry. Thrombosis Research. 136(1). 87–93.
4.
Mehilli, Julinda, Gert Richardt, Marco Valgimigli, et al.. (2013). Zotarolimus- Versus Everolimus-Eluting Stents for Unprotected Left Main Coronary Artery Disease. Journal of the American College of Cardiology. 62(22). 2075–2082.
5.
Tiroch, Klaus, Julinda Mehilli, Robert A. Byrne, et al.. (2013). Impact of Coronary Anatomy and Stenting Technique on Long-Term Outcome After Drug-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Disease. JACC: Cardiovascular Interventions. 7(1). 29–36.
6.
Estévez‐Loureiro, Rodrigo, Georg Nickenig, Stephan Baldus, et al.. (2013). TCT-86 The 2011-12 Pilot European Sentinel Registry of Percutaneous Edge-to-Edge Mitral Valve Repair: In-hospital results and mid-term follow up of 587 patients. Journal of the American College of Cardiology. 62(18). B28–B28.
7.
Tada, Tomohisa, Robert A. Byrne, Tibor Schuster, et al.. (2013). Early vascular healing with rapid breakdown biodegradable polymer sirolimus-eluting versus durable polymer everolimus-eluting stents assessed by optical coherence tomography. Cardiovascular revascularization medicine. 14(2). 84–89.
8.
Tiroch, Klaus, et al.. (2012). TCT-210 Decrease of the norepinephrine release from sympathetic nerves during renal denervation. Journal of the American College of Cardiology. 60(17). B61–B62.
9.
Byrne, Robert A., Franz–Josef Neumann, Julinda Mehilli, et al.. (2012). Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial. The Lancet. 381(9865). 461–467.
10.
Mehilli, Julinda, Jürgen Pache, Mohamed Abdel‐Wahab, et al.. (2011). Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial. The Lancet. 378(9796). 1071–1078.
11.
Mehilli, Julinda, Robert A. Byrne, Klaus Tiroch, et al.. (2010). Randomized Trial of Paclitaxel- Versus Sirolimus-Eluting Stents for Treatment of Coronary Restenosis in Sirolimus-Eluting Stents. Journal of the American College of Cardiology. 55(24). 2710–2716.
12.
Birkmeier, K. Anette, Adnan Kastrati, Robert A. Byrne, et al.. (2010). Five‐year clinical outcomes of sirolimus‐eluting versus paclitaxel‐eluting stents in high‐risk patients. Catheterization and Cardiovascular Interventions. 77(4). 494–501.
13.
Tiroch, Klaus, Dirk Sibbing, Werner Koch, et al.. (2010). Protective effect of the CYP2C19 *17 polymorphism with increased activation of clopidogrel on cardiovascular events. American Heart Journal. 160(3). 506–512.
14.
Byrne, Robert A., Adnan Kastrati, Klaus Tiroch, et al.. (2010). 2-Year Clinical and Angiographic Outcomes From a Randomized Trial of Polymer-Free Dual Drug-Eluting Stents Versus Polymer-Based Cypher and Endeavor, Drug-Eluting Stents. Journal of the American College of Cardiology. 55(23). 2536–2543.
15.
Ndrepepa, Gjin, Klaus Tiroch, Julinda Mehilli, et al.. (2010). FIVE-YEAR PROGNOSTIC VALUE OF NO-REFLOW PHENOMENON AFTER PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION. Journal of the American College of Cardiology. 55(10). A188.E1761–A188.E1761.
16.
Byrne, Robert A., Gjin Ndrepepa, Siegmund Braun, et al.. (2010). Peak Cardiac Troponin-T Level, Scintigraphic Myocardial Infarct Size and One-Year Prognosis in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction. The American Journal of Cardiology. 106(9). 1212–1217.
17.
Popma, Jeffrey J., Klaus Tiroch, Alexandra Almonacid, et al.. (2009). A Qualitative and Quantitative Angiographic Analysis of Stent Fracture Late Following Sirolimus-Eluting Stent Implantation. The American Journal of Cardiology. 103(7). 923–929.
18.
Tiroch, Klaus, Werner Koch, Julinda Mehilli, et al.. (2008). P27 and P53 Gene Polymorphisms and Restenosis following Coronary Implantation of Drug-Eluting Stents. Cardiology. 112(4). 263–269.
19.
Tiroch, Klaus, et al.. (2008). Risk Predictors of Retroperitoneal Hemorrhage Following Percutaneous Coronary Intervention. The American Journal of Cardiology. 102(11). 1473–1476.
20.
Tiroch, Klaus, et al.. (2002). Intracellular Domains of Target Antigens Influence Their Capacity to Trigger Antibody-Dependent Cell-Mediated Cytotoxicity. The Journal of Immunology. 168(7). 3275–3282.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Bart J.G.L. de Smet Breakdown of academic impact, for papers by Mark Midei Breakdown of academic impact, for papers by Raisuke Iijima Breakdown of academic impact, for papers by Jacek Legutko Breakdown of academic impact, for papers by Albert W. Chan Breakdown of academic impact, for papers by Hongsheng Wu Breakdown of academic impact, for papers by Maurits T. Dirksen Breakdown of academic impact, for papers by Ad F.M. van den Heuvel Breakdown of academic impact, for papers by Elvin Kedhi Breakdown of academic impact, for papers by Mehmet Çilingiroğlu